Search for: "Generic Pharmaceutical Services, Inc."
Results 141 - 160
of 1,028
Sorted by Relevance
|
Sort by Date
30 Oct 2014, 9:51 am
TAP Pharmaceutical Products, Inc., 518 F. [read post]
12 Mar 2008, 4:40 am
General Rent-A-Car Inc., 17 USPQ2d 1398, 1401 (S.D. [read post]
27 Jun 2013, 12:30 pm
The Department of Health and Human Services (HHS) Office of Inspector General (OIG) recently announced that it expects to recover an estimated $3.8 billion in overall recoveries for the first half of fiscal year 2013. [read post]
30 Jun 2014, 9:00 am
It announced a settlement with Omnicare Inc., the nation’s largest company supplying pharmaceuticals and related services to nursing homes and long-term care facilities. [read post]
8 May 2019, 7:14 am
Genus Lifesciences Inc. v. [read post]
3 Apr 2007, 1:43 pm
(April 2, 2007) - Océ Business Services, Inc. [read post]
24 Jun 2014, 1:52 pm
Staples, Inc., 932 F. [read post]
5 Jul 2013, 5:00 am
Astra Pharmaceutical Products, Inc., 993 F.2d 528, 538 (6th Cir. 1993). [read post]
19 Aug 2013, 6:30 am
©2013 Amaxx Risk Solutions, Inc. [read post]
15 Mar 2013, 4:41 am
Bartlett, in which the Court will consider whether federal law preempts state law design-defect claims brought against generic pharmaceutical products, here, and in Sebelius v. [read post]
12 Sep 2019, 5:44 pm
In 2017, Pfizer Inc. [read post]
31 May 2018, 9:50 am
Department of Justice announced a $23.85 million settlement with Pfizer, Inc., to settle anti-kickback claims against the company. [read post]
31 May 2018, 9:50 am
Department of Justice announced a $23.85 million settlement with Pfizer, Inc., to settle anti-kickback claims against the company. [read post]
6 Oct 2015, 11:50 pm
Abbott Laboratories is a pharmaceuticals and health care products corporation. [read post]
16 Aug 2011, 11:54 am
PCS general secretary Mark Serwotka noted, "We pay tribute to our coast guard members and people in their communities who have fought so hard to defend what is a vital public service. [read post]
8 Oct 2019, 9:44 am
Berkheimer, No. 18-415 (fact-law divide in eligibility) (waiting for views of Solicitor General) Hikma Pharmaceuticals USA Inc., et al. v. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
30 Jan 2020, 5:29 am
The Zantac litigation effort involves several international drug companies, including Boehringer Ingelheim Pharmaceuticals (based in Connecticut); Boehringer Ingelheim Corporation (German parent company); Sanofi US Services, Inc. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
8 Feb 2010, 3:43 pm
The auction generated over $3.35 million in proceeds, which resulted in net proceeds paid to Tana Seybert's estate of approximately $3.1 million (after deducting GoIndustry-DoveBid's fees).Prior to their September 2009 chapter 11 filings, Tana Seybert and its affiliates were service providers for printing and other graphic communications services, providing "a full array of services to clients in a broad range of industries: Advertising,… [read post]
